# Lisinopril and Hydrochlorothiazide

NDC: 65862-044
Generic name: Lisinopril and Hydrochlorothiazide
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20060314

FDA application: ANDA077606

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- LISINOPRIL: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-044"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-044
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7214539-6c3d-466a-a474-6fde096fa182